What is the treatment of choice for mixed phenotype ALL?
What are the differences in approach to B lymphoid/myeloid and T lymphoid/myeloid MPAL?
1 Answer
Mednet MemberInvited Expert
Pediatric Hematology/Oncology · The University of Texas MD Anderson Cancer Center
Answered on
These are difficult to treat. The limited available data suggest that an ALL–like regimen followed by HSCT may be recommended. If no response is achieved, you could try a myeloid-like strategy. For T/Myeloid, combining asparaginase with AML therapy (FA + PEG or Capizzi II) could be an option. The sp...
Join for free or sign in to see the full answer